The influence of drug solubility and particle size on the pellet formulation in a rotoprocessor

Drug Development and Industrial Pharmacy

Volumn 32, Issue 5, 2006, Pages 585-593

  Krejčová, Kateřina ^a   Rabišková, Miloslava ^a   Vetchý, David ^a   Polášek, Ermin ^a   Tomášek, Václav ^b   Prokopová, Alena ^b  

^a UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^b Pharmaceutical Development   (Czech Republic)

Author keywords

Drug cohesion; Drug solubility; Particle size; Pellet characteristics; Rotoagglomeration

Indexed keywords

DICLOFENAC; DILTIAZEM; EXCIPIENT; LACTOSE; MICROCRYSTALLINE CELLULOSE; THEOPHYLLINE; WATER;

ARTICLE; DENSITY; DEVICE; DRUG FORMULATION; DRUG PELLET; DRUG SOLUBILITY; HARDNESS; MICROSCOPY; PARTICLE SIZE; ROTOPROCESSOR;

ALGORITHMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRONCHODILATOR AGENTS; CALCIUM CHANNEL BLOCKERS; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; DILTIAZEM; DRUG COMPOUNDING; EXCIPIENTS; LACTASE; PARTICLE SIZE; SOLUBILITY; THEOPHYLLINE; WATER;

EID: 33745585802     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600599814     Document Type: Article

References (16)

1. El Saleh, F., & Kleinebudde, P. (1998). Mercury-free determination of apparent density and porosity of pellets by powder pycnometry. Pharm. Tech. Europe, 10, 18-26.
2. Ghebre-Sellassie, I. (1989). Pellets: General overview. In Pharmaceutical pelletization technology; Ghebre-Sellassie, I., Ed.; Marcel Dekker, Inc.: New York, 1-14.
3. Harris, M. R., & Ghebre-Sellassie, I. (1989). Formulation variables. In Pharmaceutical pelletization technology; Ghebre-Sellassie, I., Ed.; Marcel Dekker, Inc.: New York, 217-239.
4. Haznos, L., Langer, I., & Gyamathy, M. (1992). Some factors influencing pellet characteristics made by extrusion/spheronization process: effect on size characteristics and moisture content decrease of pellets. Drug Dev. Ind. Pharm., 18, 409-437.
5. Heng, P. W. S., Liew, C. V., & Gu, L. (2002). Influence of teardrop studs on rotating frictional base plate on spheroid quality in rotary spheronization. Int. J. Pharm., 241, 173-184.
6. Ho, H., Liu, Ch., Lin, H., & Sheu, M. (1997). The development of matrix tablets for diclofenac sodium based on an empirical in vitro and in vivo correlation. J. Contr. Rel., 49, 149-156.
7. Kim, H., & Fassihi, R. (1997). Application of a binary polymer system in drug release rate modulation: 2. Influence of formulation variables and hydrodynamic conditions of release kinetics. J. Pharm. Sci., 86, 323-328.
8. Kristensen, J., Schaefer, T., & Kleinebudde, P. (2000). Direct pelletization in a rotary processor controlled by torque measurements. Pharm. Dev. Technol., 5, 247-256.
9. Liew, C. V., Wan, L. S. C., & Heng, P. W. S. (2000). Role of base plate rotational speed in controlling spheroid size distribution and minimizing oversize particle formation during spheroid production by rotary processing. Drug Dev. Ind. Pharm., 26, 953-963.
10. Martin, A., Swarbrick, J., & Cammarata, A. (1983). Kinetics. In Physical Pharmacy; Martin, A. et al. Eds.; Lea & Febiger: Philadelphia, 352-398.
11. Rabišková, M. (2001). Extrusion technology. In Microencapsulation of food ingredients; Vilstrup, P. Ed.; Leatherhead Publishing LFRA: Surrey, 224-248.
12. Rowe, R. C., Sheskey, P. J., & Weller P. J. (2003). Handbook of Pharmaceutical Excipients; The Pharmaceutical Press: London.
13. Sienkiewicz, G., Pereira, R., Rudnic, E. M., Lausier, J. M., & Rhodes C. T. (1997). Spheronization of theophylline - Avicel combinations using a fluidized-bed rotogranulation technique. Drug Dev. Ind. Pharm., 23, 173-182.
14. Stewart, P. J., & Zhao, F. (2005). Understanding agglomeration of indomethacin during the dissolution of micronized indomethacin mixtures through dissolution and de-agglomeration modeling approaches. Eur. J. Pharm. Biopharm., 59, 315-323.
15. Vertommen, J., & Kinget R. (1997). The influence of five selected processing and formulation variables on the particle size, particle size distribution and friability of pellets produced in a rotary processor. Drug Dev. Ind. Pharm., 23, 39-46.
16. Vetchý, D., & Rabišková M. (2002). Some variables influencing rotoagglomeration in the multiprocessor MP-1. Int. J. Pharm., 242, 353-356.